1233237-24-5

Basic information

• Product Name: tert-butyl-4-(2-(4-(5-(2,4-difluorophenoxy)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)phenoxy)ethyl)piperazine-1-carboxylate
• Synonyms: tert-butyl-4-(2-(4-(5-(2,4-difluorophenoxy)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)phenoxy)ethyl)piperazine-1-carboxylate
• CAS NO: 1233237-24-5
• Molecular Weight: 518.517
• Mol File: 1233237-24-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl-4-(2-(4-(5-(2,4-difluorophenoxy)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)phenoxy)ethyl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl-4-(2-(4-(5-(2,4-difluorophenoxy)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)phenoxy)ethyl)piperazine-1-carboxylate(1233237-24-5)
• EPA Substance Registry System: tert-butyl-4-(2-(4-(5-(2,4-difluorophenoxy)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)phenoxy)ethyl)piperazine-1-carboxylate(1233237-24-5)

Safety Data

• Hazardous Substances Data: 1233237-24-5(Hazardous Substances Data)

Upstream product

• 1169937-37-4 5-(2,4-difluorophenoxy)-3-(4-hydroxyphenyl)-1,3,4-oxadiazol-2(3H)-one 
• 77279-24-4 tert-butyl 4-(2-hydroxyethyl)piperazine-1-carboxylate 

Relevant articles and documents

5-O-SUBSTITUTED 3-N-ARYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE

The present invention relates to a compound of formula (I), wherein A represents an optionally substituted phenyl or a 5- or 6-membered heteroaromatic ring system containing up to 4 heteroatoms selected from O, S and N, B represents a single bond, O, S or NR1, wherein R1 is selected from hydrogen or a C1-C6-alkyl group; L represents a linker; C represents an amino moiety; n represents 0 or 1; m represents 0, 1, 2, 3, 4, 5 or 6; X represents O or S; and Y represents hydrogen or an optionally substituted carbon moiety; and to stereoisomers, pharmaceutically acceptable salts or esters, or prodrugs thereof. The compounds of the invention are potent FAAH inhibitors.